The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1 H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)
Open accessAbstract
A series of sulfonamide-containing 1,5-diarylpyrazole derivatives were prepared and evaluated for their ability to block cyclooxygenase-2 (COX-2) in vitro and in vivo. Extensive structure-activity relationship (SAR) work was carried out within this series, and a number of potent and selective inhibitors of COX-2 were identified. Since an early structural lead (1f, SC-236) exhibited an unacceptably long plasma half-life, a number of pyrazole analogs containing potential metabolic sites were evaluated further in vivo in an effort to identify compounds with acceptable pharmacokinetic profiles. This work led to the identification of 1i (4-[5-(4-methylphenyl)-3-(trifluoromethyl)- H-pyrazol-1-yl]benzenesulfonamide, SC-58635, celecoxib), which is currently in phase III clinical trials for the treatment of rheumatoid arthritis and osteoarthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs
Winter, C. A., Risley, E. A., & Nuss, G. W. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-111-27849 · Cited by 5,688
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Self-citationAspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationRenal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,122
Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs
Allison, M. C., Howatson, A. G., Torrance, C. J., Lee, F. D., & Russell, R. I. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271101 · Cited by 958
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 826
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., & Seibert, K. (1995) · Biochemical Journal · doi:10.1042/bj3050479 · Cited by 412
Self-citation
Cited by
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Ecotoxicology of human pharmaceuticals
Fent, K., Weston, A. A., & Caminada, D. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2005.09.009 · Cited by 3,223
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Introduction of Fluorine and Fluorine‐Containing Functional Groups
Liang, T., Neumann, C. N., & Ritter, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201206566 · Cited by 2,564
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Click-Chemie: diverse chemische Funktionalität mit einer Handvoll guter Reaktionen
Kolb, H. C., Finn, M. G., & Sharpless, K. B. (2001) · Angewandte Chemie · doi:10.1002/1521-3757(20010601)113:11<2056::aid-ange2056>3.0.co;2-w · Cited by 1,624
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
The Many Roles of Computation in Drug Discovery
Jorgensen, W. L. (2004) · Science · doi:10.1126/science.1096361 · Cited by 1,554
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
Fustero, S., Sánchez-Roselló, M., Barrio, P., & Simón-Fuentes, A. (2011) · Chemical Reviews · doi:10.1021/cr2000459 · Cited by 1,155
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Fluorine in health care: Organofluorine containing blockbuster drugs
O’Hagan, D. (2010) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2010.03.003 · Cited by 856
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Self-citationThe role of fluorine in medicinal chemistry: Review Article
Shah, P., & Westwell, A. D. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701425014 · Cited by 799
Simon, L. S., Weaver, A. L., Graham, D. Y., Kivitz, A. J., Lipsky, P. E., Hubbard, R. C., Isakson, P. C., Verburg, K. M., Yu, S. S., Zhao, W. W., et al. (1999) · JAMA · doi:10.1001/jama.282.20.1921 · Cited by 798
Self-citationRao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Talley, J. J., Brown, D. L., Carter, J. S., Graneto, M. J., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Rogers, R. S., Shaffer, A. F., Zhang, Y. Y., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990577v · Cited by 638
Self-citationBellina, F., & Rossi, R. (2006) · Tetrahedron · doi:10.1016/j.tet.2006.05.024 · Cited by 606
Prodrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554
Emery, P., Zeidler, H., Kvien, T. K., Guslandi, M., Naudin, R., Stead, H., Verburg, K. M., Isakson, P. C., Hubbard, R. C., & Geis, G. S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02332-6 · Cited by 543
Self-citationChemical Aspects of Human and Environmental Overload with Fluorine
Han, J., Kiss, L., Mei, H., Remete, A. M., Ponikvar-Svet, M., Sedgwick, D. M., Roman, R., Fustero, S., Moriwaki, H., & Soloshonok, V. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01263 · Cited by 537
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
Zhu, W., Wang, J., Wang, S., Gu, Z., Aceña, J. L., Izawa, K., Liu, H., & Soloshonok, V. A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.026 · Cited by 493
Dai, H.-X., Stepan, A. F., Plummer, M. S., Zhang, Y.-H., & Yu, J.-Q. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201708f · Cited by 480
Self-citationRiendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de Novo Recruitment of Brown Adipocytes
Vegiopoulos, A., Müller-Decker, K., Strzoda, D., Schmitt, I., Chichelnitskiy, E., Ostertag, A., Diaz, M. B., Rozman, J., Hrabe de Angelis, M., Nüsing, R. M., et al. (2010) · Science · doi:10.1126/science.1186034 · Cited by 459
Prasit, P., Wang, Z., Brideau, C., Chan, C.-C., Charleson, S., Cromlish, W., Ethier, D., Evans, J. F., Ford-Hutchinson, A. W., Gauthier, J. Y., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00288-7 · Cited by 429
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor
Davies, N. M., McLachlan, A. J., Day, R. O., & Williams, K. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038030-00003 · Cited by 424
Chan, C.-C., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Ford-Hutchinson, A. W., Forrest, M. J., Gauthier, J. Y., et al. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34934-1 · Cited by 398
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Self-citationBensen, W. G., Fiechtner, J. J., McMillen, J. I., Zhao, W. W., Yu, S. S., Woods, E. M., Hubbard, R. C., Isakson, P. C., Verburg, K. M., & Geis, G. S. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.11.1095 · Cited by 348
Self-citationCyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation
Nantel, F., Denis, D., Gordon, R., Northey, A., Cirino, M., Metters, K. M., & Chan, C. C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702866 · Cited by 333
Evans, J. F., Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., & Taketo, M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02780.x · Cited by 333
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329
Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N. M., & Han, R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1939 · Cited by 328
The Role of Biomechanics and Inflammation in Cartilage Injury and Repair
Guilak, F., Fermor, B., Keefe, F. J., Kraus, V. B., Olson, S. A., Pisetsky, D. S., Setton, L. A., & Weinberg, J. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000131233.83640.91 · Cited by 325
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Kalgutkar, A. S., Marnett, A. B., Crews, B. C., Remmel, R. P., & Marnett, L. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000004e · Cited by 316
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor
GOLDSTEIN, J., SILVERSTEIN, F., AGRAWAL, N., HUBBARD, R., KAISER, J., MAURATH, C., VERBURG, K., & GEIS, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00986-2 · Cited by 308
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
Hegen, M., Keith, J. C., Collins, M., & Nickerson-Nutter, C. L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076430 · Cited by 305
Identification of Direct Protein Targets of Small Molecules
Lomenick, B., Olsen, R. W., & Huang, J. (2011) · ACS Chemical Biology · doi:10.1021/cb100294v · Cited by 299
Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Multicomponent syntheses of functional chromophores
Levi, L., & Müller, T. J. J. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00805k · Cited by 289
Celecoxib: A Review of its Use in Osteoarthritis, Rheumatoid Arthritis and Acute Pain
Clemett, D., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00017 · Cited by 287
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Self-citationFluorine in Medicinal Chemistry
Swallow, S. (2015) · Progress in Medicinal Chemistry · doi:10.1016/bs.pmch.2014.11.001 · Cited by 280
Yaksh, T. L., Dirig, D. M., Conway, C. M., Svensson, C., Luo, Z. D., & Isakson, P. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05847.2001 · Cited by 270
Self-citationCox-2-Selective Inhibitors: The New Super Aspirins
DeWitt, D. L. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23023-6 · Cited by 261
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
Bellina, F., Cauteruccio, S., & Rossi, R. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.02.075 · Cited by 254
Myint, K.-Z., Wang, L., Tong, Q., & Xie, X.-Q. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300237z · Cited by 139
Loftin, C. D., Trivedi, D. B., & Langenbach, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214924 · Cited by 65
Zobdeh, F., Eremenko, I. I., Akan, M. A., Tarasov, V. V., Chubarev, V. N., Schiöth, H. B., & Mwinyi, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061190 · Cited by 45
Endesh, N., Chuntharpursat‐Bon, E., Revill, C., Yuldasheva, N. Y., Futers, T. S., Parsonage, G., Humphreys, N., Adamson, A., Morley, L. C., Cubbon, R. M., et al. (2023) · Liver International · doi:10.1111/liv.15646 · Cited by 44
Myint, K. Z., & Xie, X.-Q. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2239-0_9 · Cited by 21
Metadata
- Authors
- Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., Rogers, R. S., Rogier, D. J., Yu, S. S., Anderson, G. D., Burton, E. G., Cogburn, J. N., Gregory, S. A., Koboldt, C. M., Perkins, W. E., Seibert, K., Veenhuizen, A. W., Zhang, Y. Y., & Isakson, P. C.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-04-01
- Volume
- 40
- Issue
- 9
- Pages
- 1347-1365
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2033498682
- Cited by
- 1,965
- References
- 14
- FWCI
- 47.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.